GeneDx officer plans $458K stock sale under Rule 144
GeneDx Holdings Corp. (WGS) received a notice that officer Kevin Feeley has filed to sell up to 5,410 shares of Class A common stock under Rule 144 through Morgan Stanley Smith Barney, with an approximate sale date of September 1, 2026 on NASDAQ.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
GeneDx Holdings Corp. (WGS) received a notice that officer Kevin Feeley has filed to sell up to 5,410 shares of Class A common stock under Rule 144 through Morgan Stanley Smith Barney, with an approximate sale date of September 1, 2026 on NASDAQ.
The shares relate to anticipated vesting of restricted stock units in three tranches of 372, 1,284, and 3,754 shares in September 2026. Feeley previously sold 5,364 shares during June 2026 to cover tax withholding obligations from RSU vesting.
Key Figures
Key Terms
Rule 144 regulatory
Restricted Stock Units financial
aggregate market value financial
tax withholding obligations financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider sale has been filed for GeneDx Holdings Corp. (WGS)?
What is the nature of Kevin Feeley’s compensation underlying the WGS Form 144 filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.